This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 75
years old
The phase for this study is not defined.
Show me locations

The purpose

While electroconvulsive therapy (ECT) in major depression is effective, high relapse rates and cognitive side effects limit its long-term use. There is no consensus about optimal continuation pharmacological treatments after a ECT course. Adjunction of tDCS to pharmacological continuation treatment after ECT may decrease relapse rates.

Provided treatments

  • Device: Device : Transcranial direct current stimulation
  • Device: Device : sham Transcranial direct current stimulation

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02886858. The sponsor of the trial is Hôpital le Vinatier and it is looking for 1 volunteers for the current phase.
Official trial title:
tDCS as Continuation Treatment to Sustain Remission After Electroconvulsive Therapy in Depression